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The mzIdentML Data Standard Version 1.2,
Supporting Advances in Proteome Informatics*□S
Juan Antonio Vizcaíno‡, Gerhard Mayer§, Simon Perkins¶, Harald Barsnes**‡‡,
Marc Vaudel‡‡§§, Yasset Perez-Riverol‡, Tobias Ternent‡, Julian Uszkoreit§,
Martin Eisenacher§, Lutz Fischer¶¶, Juri Rappsilber¶¶, Eugen Netza,
Mathias Walzerb, Oliver Kohlbachera,b,c,d, Alexander Leitnere, Robert J. Chalkleyf,
Fawaz Ghali¶, Salvador Martínez-Bartolome´g, Eric W. Deutschh,
and Andrew R. Jones¶i
The first stable version of the Proteomics Standards Ini-
tiative mzIdentML open data standard (version 1.1) was
published in 2012—capturing the outputs of peptide and
protein identification software. In the intervening years,
the standard has become well-supported in both com-
mercial and open software, as well as a submission and
download format for public repositories. Here we report a
new release of mzIdentML (version 1.2) that is required to
keep pace with emerging practice in proteome informat-
ics. New features have been added to support: (1) scores
associated with localization of modifications on peptides;
(2) statistics performed at the level of peptides; (3) iden-
tification of cross-linked peptides; and (4) support for
proteogenomics approaches. In addition, there is now
improved support for the encoding of de novo sequencing
of peptides, spectral library searches, and protein infer-
ence. As a key point, the underlying XML schema has only
undergone very minor modifications to simplify as much
as possible the transition from version 1.1 to version 1.2
for implementers, but there have been several notable
updates to the format specification, implementation
guidelines, controlled vocabularies and validation soft-
ware. mzIdentML 1.2 can be described as backwards com-
patible, in that reading software designed for mzIdentML
1.1 should function in most cases without adaptation. We
anticipate that these developments will provide a continued
stable base for software teams working to implement the
standard. All the related documentation is accessible at
http://www.psidev.info/mzidentml. Molecular & Cellular
Proteomics 16: 10.1074/mcp.M117.068429, 1275–1285,
2017.
The Proteomics Standards Initiative (PSI)1 has taken the
role of developing standard file formats for different aspects
of mass spectrometry (MS) based analysis (for a review see
(1)). These include the mzML format, which can store raw MS
data suitable for quantitation processes, as well as processed
peak lists for searching (2). Downstream of mzML, several
formats serve different use cases. To capture the results of
identification approaches, such as the use of proteomics
search engines, the mzIdentML format was released as a
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stable version (version 1.1) in the last quarter of 2011, and
published in 2012 (3). A separate format for quantitative re-
sults was built, called mzQuantML—initially defined for large
scale discovery approaches (4) and updated to also support
targeted approaches, such as selected reaction monitoring
(5). More recently, in 2014, a lighter tab-delimited format
called mzTab was also developed by the PSI to capture
identification and quantification results (6).
mzML, mzIdentML, and mzQuantML are represented in the
Extensible Markup Language (XML). The three formats are
defined by an XML Schema Definition (XSD) file, which have
all been fixed on a version for some time: mzML (version 1.1
since 2009), mzIdentML (version 1.1 since 2011), and
mzQuantML (version 1.0 since 2013). The PSI has also built a
large controlled vocabulary (CV), the PSI-MS CV (7), contain-
ing more than 2700 terms and definitions in a structured
hierarchy (version 4.0.12, May 2017). To ensure that terms are
used correctly within the formats, an additional mechanism
has been built on top of XSD validation, called PSI semantic
validation (8). This mechanism is encoded as a CV mapping
file listing all places in each format where CV terms are al-
lowed, and specifying a branch or branches of the PSI-MS CV
where terms can be sourced, called a semantic rule. Each
semantic rule is accompanied by a requirement level - MAY,
SHOULD or MUST (formal keywords), triggering behavior in
custom validation software (information, warning, and error,
respectively). To create a valid mzIdentML file thus requires it
to be syntactically correct (passing XSD validation) and se-
mantically correct (passing PSI semantic validation i.e. in-
tended CV terms are present and correct), and these features
have been implemented in validation software (9).
Since its initial stable release, the adoption of mzIdentML
1.1 has increased enormously (Table I). Most notably, several
popular proteomics software now export mzIdentML natively,
and this list is growing regularly. This includes analysis tools
such as MS-GF (10), Mascot (Matrix Science, London, UK,
from version 2.4), ProteinPilot (SCIEX, Framingham, MA,
from version 5.0), ProteinLynx Global Server (Waters Corp.,
Milford, MA, from version 3.0.3 onwards), PEAKS (Bioinfor-
matics Solutions, Waterloo, Canada) (11), Scaffold (Proteome
Software, Portland, OR) (12), Byonic (Protein Metrics), Myri-
Match (13), PeptideShaker (14), Crux (15), OpenMS (16), mzID
in Bioconductor (17), and PIA (Protein Inference Algorithms)
(18). It is also planned that ProteomeDiscoverer (Thermo
Fisher Scientific, Waltham, MA) will export the format natively
in its next version, to be released later in 2017. It is used as an
import format to quantitation software, such as Progenesis QI
for proteomics (Waters Corp.) e.g. to import results from
Byonic. In addition, it is becoming increasingly common that
mzIdentML becomes the final output of analysis pipelines,
e.g. ProteoAnnotator (19). For software not natively imple-
menting the format, some converters are available, e.g. Pro-
Con (20) and ProteoWizard (21). Visualization software for
mzIdentML files is also now available, most notably the open
source PRIDE Inspector tool (22), which was updated in 2016
to fully support mzIdentML, and the ProteoIDViewer (9). Some
of these tools are reusing open source libraries tailored to the
format such as jmzIdentML (23), mzid Library (9), and the
ms-data-core-api (24). Finally, it is important to highlight that
mzIdentML is now fully supported as a data submission for-
mat, via the “complete” submission mechanism (enabling full
search capabilities and visualization of the data), to the
PRIDE, MassIVE, and jPOST data repositories, as part of the
ProteomeXchange Consortium (25).
An important consideration for data standards is the bal-
ance between stability and innovation. A standard that is
updated at regular intervals causes problems for the devel-
oper community—including those writing exporters from their
own software, as well as those wishing to write parsers for
data produced by others. However, it is also important for
standards organisations to update formats periodically as the
requirements of the field evolve. In this article, we are report-
ing an update from mzIdentML version 1.1 to version 1.2 to
cope with several features that have been requested by soft-
ware teams or by the wider proteomics community, and that
were not specified previously. New features have generally
been implemented by adding new CV terms to the format,
and updating the way in which terms are used in a valid
mzIdentML file as opposed to making changes to the XML
schema itself. However, several minor updates have been
made to the mzIdentML XSD file to fix bugs or important
omissions (for example concerning whether elements are
mandatory or optional), which will overall improve the ease of
development around the format. The background to the major
new features and improvements is summarized in the follow-
ing sections. The changes made to mzIdentML 1.2 can be
described as backwards compatible, in that reading software
designed for mzIdentML 1.1 should function in most cases
without adaptation. It is understood that standards should
remain stable for significant periods of time to ensure ease of
adoption by the developer community, and as such, we have
attempted to add new features in a manner that will make it
as straightforward as possible for existing adopters of the
format.
Modification Localization—Even if the identification of a
peptide carrying one or more post-translational modifications
(PTMs) or chemical modifications can be confirmed with high
certainty, the exact residue on which the modification resides
may be ambiguous, particularly for modifications that are
known to occur on multiple residues, such as phosphorylation
on S, T, or Y. A variety of approaches have been developed
that give scores or statistical measures to modification local-
ization, as reviewed in (26). There is a growing interest in
annotating proteomes with previously “confirmed” PTM sites
on proteins, and thus if MS-derived data is to be used for this
purpose, it is imperative that the evidence trail is adequately
reported in the standard, which could not previously be
achieved in a clear way.
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Cross-linking—Cross-linking MS has become a standard
tool in structural biology investigations of multiprotein com-
plexes (27) and can lead to detailed models of proteins (28).
The principle of the technique involves the use of a chemical
reagent to cross-link residues close in physical space in the
three-dimensional structure of a protein or protein complex.
Cross-linked peptides are identified by database searching
and can reveal which residues are in close proximity in the
folded proteins. For instance, such information can be inte-
grated with other sources in structural biology to compute
structures of biomolecular systems (29). Upwards of 30 spe-
cifically designed search engines and associated statistical
techniques are available for identifying cross-linked peptides.
The data types resulting from such software require consid-
erable changes to the standard reporting guidelines as used
in the rest of the proteomics field.
Peptide-level Statistics—In large-scale (discovery) pro-
teomics MS/MS approaches, there has been much work over
the last two decades to improve statistical approaches, to
ensure that results from different analytical pipelines are more
comparable and to accurately estimate the false discovery
rate (FDR). The approach as first described was applied to
peptide-spectrum matches (PSMs), and the field adopted a
consensus 1% FDR threshold. However, high intensity pep-
tides eluting over a retention time higher than the dynamic
exclusion of the instrument generate high-similarity fragment
spectra which, when correctly identified, result in redundant
PSMs, whereas false positives are more evenly distributed
across peptides. As a result, if a fixed threshold (e.g. 1%) is
used for false discovery at the PSM-level, it is likely that the
actual level of false discovery at the peptide-level is some-
what higher. This phenomenon is important in a variety of
cases, for example the identification of phosphopeptides (or
peptides containing other PTMs) or in the annotation of ge-
nomes, where it is important to control FDR at the level of the
individual peptide sequence. Consequently, new structures
have been added to mzIdentML 1.2 to support the grouping of
PSMs into peptide units, and the reporting of scores for
peptides (as well or instead of PSM scores).
Proteogenomics—In these approaches (30), searches are
performed against databases that are generated using
genomic and/or transcriptomic sequence information, from
which novel peptides and sequence variants can be identified.
One of the key concepts required is the mapping of peptides
back to gene models and chromosomes, for example dem-
onstrating evidence where peptides map across splice junc-
tions. To ensure that a consistent export is possible from
mzIdentML to formats designed specifically for genome visu-
alization or annotation, e.g. the BED or SAM/BAM formats
(31), and their recently developed proteomics counterpart PSI
formats proBed (see http://www.psidev.info/probed) and pro-
BAM (http://www.psidev.info/probam), in mzIdentML 1.2, a
consistent encoding of the chromosomal mappings for pep-
tides has been developed.
Protein Grouping—The protein inference problem has been
widely discussed in the literature (32, 33). Most identification
pipelines now report grouped protein identifications where
ambiguity cannot be resolved e.g. proteins have been identi-
fied from the same set of peptides. For each group, one or
more leading or representative proteins can be reported. In
mzIdentML 1.1, a two-level hierarchy was defined for captur-
ing evidence at the level of the group, and the level of indi-
vidual database accession numbers. However, a higher-level
concept emerged in some approaches of a protein cluster or
family (34), inside which groups of different proteins shared
some peptides in common, but also had independent evi-
dence. The mzIdentML 1.1 specifications left the developers
of export software to choose how to use these structures, and
the result is that inconsistencies arose around the encoding of
clusters/families (which were not explicitly mentioned in the
format specification), as well as the definition of group leading
proteins. A PSI working group investigated the issue at length,
taking on board a wide range of opinions, and examining all
popular approaches in software. From the working group a
new specification emerged, described previously (35), and
now included in this stable release of mzIdentML 1.2.
EXPERIMENTAL PROCEDURES
The development of mzIdentML 1.2 started in 2012 and it has been
an open process via conference calls, discussions at the PSI annual
meetings and smaller workshops. The specifications have been sub-
mitted to the PSI document process (36) for review, during which time
external reviewers can provide feedback on the specifications and
they are available for public comments, enabling broad input on the
specifications. The model is accompanied by CV terms and defini-
tions as part of the PSI-MS CV, also used in other PSI data formats
and actively maintained by the PSI MS and PI (Proteomics Informat-
ics) working groups, as well as a newly developed CV for cross-linking
reagents and modifications called XLMOD-CV. The complete
mzIdentML 1.2 specification document, the new XLMOD-CV, example
files and additional documentation can be found at http://www.
psidev.info/mzidentml.
mzIdentML Overview—Here we briefly describe the structure of
mzIdentML files, as a basis for demonstrating the mechanism used to
add the new features. As mentioned above, this overall file structure
is nearly identical in mzIdentML 1.2 and mzIdentML 1.1. We have
attempted to encode the new use cases without changing the core
model of the format, to simplify adoption by the developer commu-
nity. The core model is summarized in Fig. 1. The core data type in
proteomics identification approaches (by MS/MS) is the PSM. Most,
search engines output one or more ranked explanations (peptide
sequences) that match each collected MS/MS fragmentation spec-
trum, associated with scores or statistical values. In mzIdentML, such
data is recorded in a section of the file, called the Spectrum-
IdentificationList, which contains a set of elements called
SpectrumIdentificationResult, each storing all reported identifica-
tions from a single spectrum. One SpectrumIdentificationResult
has an attribute enabling reading software to identify the spectrum
that was searched (in an external file), then lists an ordered set of
SpectrumIdentificationItem elements, each one being a single
PSM. The key attributes of the SpectrumIdentificationItem are the
calculated and experimental m/z values, the rank, a reference to the
peptide that has been identified, and an additional set of scores or
statistics, represented as CV terms (list of cvParam elements). An
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example PSM represented in mzIdentML (either in version 1.1 or 1.2,
the representation does not change) is given in Fig. 1A. The peptide_
ref element contains a reference to a separate element in the file
containing the Peptide object, such that if multiple PSMs identify
the same peptide, the peptide details are only recorded once in the
file to save space (Fig. 1B).
The SpectrumIdentificationItem also has one or more Peptide-
EvidenceRef elements (Fig. 1C), which reference to a second
external object, capturing the protein sequences in which the peptide
can be found (assuming a digestion with the given enzyme rules). The
PeptideEvidence element also refers to thePeptide object and
has a second external reference to DBSequence, which captures
a protein sequence entry in the database that was searched (Fig. 1D).
Protein and grouped protein results are held in a separate part of
the file, called the ProteinDetectionList. A set of proteins with
shared evidence are reported under ProteinAmbiguityGroup, and
the evidence for a single protein accession number being identified is
captured under ProteinDetectionHypothesis, which references
the set of PSMs (SpectrumIdentificationItem elements) on which it
is based (Fig. 1E). For a complete description of the mzIdentML
FIG. 1. A, A single PSM is represented within <SpectrumIdentificationItem> including scores as values associated with standard
terms sourced from the PSI-MS controlled vocabulary. Unique identifiers and references to other objects in the file are underlined. B, The
peptide identified is stored elsewhere in the file, within the Peptide element, which can be referenced by an unlimited number of PSMs. C,
All the proteins within which a peptide sequence can be located (given the enzyme specificity as defined) are linked via thePeptideEvidence
element. D, Database proteins are represented in DBSequence. E, An identified group of proteins is stored within ProteinAmbiguity-
Group (“Protein group” on the right panel) and ProteinDetectionHypothesis (PDH) - evidence at the level of a single database accession.
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specification, see the original publication (3) and the PSI website
(http://www.psidev.info/mzidentml).
RESULTS AND DISCUSSION
The following section describes the implementation of new
features in mzIdentML 1.2 only. Because of the complexity
and diversity of analysis workflows that need to be repre-
sented in the mzIdentML 1.2 format, a “flag” was added in the
top part of the file, which enables reading software to deter-
mine which, if any, new features have been added and need
to be considered. This mandatory requirement is met by
adding an additional CV term in the SpectrumIdentification-
Protocol element depending on the type of workflow repre-
sented (Table II).
Modification Position Scoring—First, to ensure that down-
stream software is aware that a file contains modifica-
tion position scores, a CV term is added to the Spectrum-
IdentificationProtocol called “modification localization
scoring” (MS:1002491), as shown in Fig. 2. Once this term is
detected in the file, the validation (and reading) software ex-
pect the following additional features to be present. First,
some approaches apply a statistical threshold for accepting
or rejecting that a modification position has been confidently
identified, which can be reported in the Threshold ele-
ment. The (re-usable) Peptide element has an attribute via
which the residue and location of a modification can be re-
corded. To remain backwards compatible, we recommend
that the software implementing modification scoring in mzI-
dentML should continue to use these attributes, populating it
with the most likely modification position. A new CV term
(mandatory when MS:1002491 is present in SpectrumIden-
tificationProtocol) must be added to every Modification
element, called “modification index” (MS:1002504), where the
value serves as a unique identifier (local only to the containing
Peptide) to be referenced from SpectrumIdentificationI-
tem. The modification scores (from any algorithm or scoring
system) themselves can be added as CV terms with a value
provided as a regular expression of four values in a defined
order: MOD_INDEX, SCORE, POSITION, PASS_THRESHOLD.
MOD_INDEX is a reference to the “modification index” iden-
tifier provided in the referenced Peptide  Modifica-
tion element. This is required in case there are two or more
different types of modification on the same peptide, which
could otherwise not be distinguished by position alone. The
MOD_INDEX thus ensures that the correct CV term for the
modification being scored is referenced. SCORE is the score
or statistical value for the given position. POSITION is
the scored modification position with respect to the peptide
sequence (where position  0 is used to indicate the N termi-
nus, and position  peptide length1 is used to indicate the
C terminus). The POSITION can include the bar symbol ‘’, as
a logical OR, if the score relates to multiple positions that
cannot be distinguished. PASS_THRESHOLD holds a Bool-
ean (true, false) value to indicate whether the modification
position passes the threshold described above. If a reader of
a file wishes to determine all the sites identified without am-
biguity given the threshold written to the file, one could re-
trieve all those PSMs with modification scores having PASS_
THRESHOLD equals true.
Where modification position scoring, and similarly peptide-
level statistics (discussed below), have been performed by
post-processing software rather than the initial search engine,
any relevant parameters of the post-processing should be
added under AdditionalSearchParams, and the software
description under AnalysisSoftwareList (not shown).
MS/MS cross-linking approaches—Search engines that are
able to identify cross-linked peptides report PSMs in a
broadly similar manner to regular search engines. However,
where an identification is made indicating that a spectrum
matches a cross-linked pair of peptides, there may be a score
for the overall identification, as well as independent scores for
the alpha (cross-link donor) and beta (cross-link acceptor)
peptides. This arises because it is common for fragment
products to be identified only from one or the other peptide
chain, and thus a given result may include higher confidence
TABLE II
New CV terms in the PSI-MS CV that are now mandatory within the element SpectrumIdentificationProtocol, enabling the new features in
mzIdentML 1.2 to be differentiated and recognized automatically by processing software. In the file, 1 . . . n of the terms MUST be present
CV term name Accession number Comments/Purpose
Peptide-level scoring MS:1002490 Statistics have been performed on non-redundant peptide identifications.
Modification localization scoring MS:1002491 Scoring has been performed on the sites of peptide modification.
Consensus scoring MS:1002492 Multiple search engines have been used for peptide identification.
Sample prefractionation MS:1002493 The file contains the results of merged pre-fractionation analyses.
Cross-linking search MS:1002494 The search engine has analysed cross-linked (and regular) peptides, using the new
encoding described here.
De novo search MS:1001010 De novo sequencing of peptides has been performed, meaning that 0 . . n
relationships from peptides to proteins are allowed (rather than 1 . . n).
Proteogenomics search MS:1002635 Peptides have been mapped back to genome level coordinates, stored in the file.
Spectral library search MS:1001031 The identifications have been made by searching against a spectral library. 0 . . n
peptides to proteins are allowed (rather than 1 . . n elsewhere) for cases where
peptide to protein relationships are unknown in the library, or where a library
entry has been identified with no known peptide sequence.
No special processing MS:1002495 Used to indicate that none of the above features have been included in the file.
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in one peptide than in the other (37). To fulfil these require-
ments in mzIdentML 1.2, the following adaptations were
made (Fig. 3). First, the SpectrumIdentificationProtocol
must contain the CV term “cross-linking search” (MS:
1002494) as shown in Fig. 3B. Once this term is detected in
the file, the validation and implementing software will expect
the following features to be present. First, a mechanism has
been added for relating two different Peptide elements
together, using the CV terms “cross-link donor” and “cross-
link acceptor” where an identical (and within-file unique) value
indicates that they are grouped together (Fig. 3C). TheMod-
ification element has an attribute called monoisotopicMass-
Delta, and by convention it is expected that the cross-link
donor contains the complete mass delta introduced by the
cross-linking reagent, and that the cross-link acceptor reports
a mass shift delta of zero. As no current CV is designed for
cross-linking modifications, to capture the modification
masses, site specificity and common names for cross-linking
reagents, we have created a new CV (XLMOD-CV) to which
new terms can be added by request.
Second, a convention was also introduced within a given
SpectrumIdentificationResult. There, a pair of cross-
linked peptides are reported as two instances of Spectrum-
IdentificationItem linked together by sharing the same value
for the rank attribute, and through having a shared local
unique identifier as the value for the CV term “cross-link
spectrum identification item” (MS:1002511), as shown in Fig.
3D. If the search engine has produced a single score for the
cross-linked pair, both SpectrumIdentificationItem ele-
ments must carry the identical score (same CV term name
and value, as in Fig. 3D), but the two chains may also have
additional, independent scores if needed (not shown). Finally,
mechanisms have also been developed that enable evidence
derived from cross-linked peptides pairs containing differen-
tial stable isotope labels to be encoded, as well as protein
interaction evidence (not shown, see the specification docu-
ment for more details). This overall mechanism can be ex-
tended to report more than two peptides that are sequentially
cross-linked. More complex scenarios are not supported in
mzIdentML 1.2.
FIG. 2. A, Graphical representation of the strength of evidence associated with one phosphorylation event on the peptide DNSTM-
GYMMAK. B, If modification re-scoring has been performed, the protocol must be flagged with the specific CV term and a threshold can be
specified as to whether a given modification position has been confidently identified. C, The peptide and modification are represented in the
re-usable Peptide and Modification elements. D, Modification localization scores are included within SpectrumIdentificationItem
following a given syntax: MOD_INDEX:SCORE:POSITION:PASS_THRESHOLD, where MOD_INDEX is the value referenced, allowing different
modification types within a given Peptide element to be referenced, and POSITION is the position along the peptide chain (zero  N
terminus; peptide-length  1  C terminus).
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Peptide-level Statistics—To encode peptide-level scores or
statistics in mzIdentML, first, an additional CV term “peptide-
level scoring” (MS:1002490) must be included in Spectrum-
IdentificationProtocol (supplemental Fig. S1). Second, there
are various mechanisms by which a set of PSMs can be
collapsed down to a peptide-level, depending on the purpose
of the routine. In contexts such as genome annotation, an
application may only require evidence for whether a given
peptide sequence has been confidently identified regardless
of its modification status, and thus different PSMs giving
evidence for both modified and unmodified forms of the pep-
tide could be grouped together. In other cases, such as
providing evidence for particular PTMs, grouping of PSMs
into peptides must differentiate between modification sta-
tuses. Three CV terms have been added to the PSI-MS CV:
“group PSMs by sequence” (MS:1002496), “group PSMs
by sequence with modifications” (MS:1002497), and “group
PSMs by sequence with modifications and charge” (MS:
1002498) to cover the most common scenarios. Further CV
terms for other grouping mechanisms can be added on re-
quest. One of the main reasons for performing peptide-level
analysis is to apply a threshold, such as 1% FDR, for selecting
data for downstream analysis, which can now be added to the
search protocol. In addition, as explained, a mechanism is
then needed for capturing how different PSMs are grouped
into a single peptide. This is achieved by adding a CV term
“peptide group ID” (MS:1002520) to every PSM (Spectrum-
IdentificationItem) in the file, whereby the associated value
is a unique identifier shared between all PSMs in the same
peptide group. In supplemental Fig. S1, the unique identifier
FIG. 3. A, A graphical representation of the cross-linked peptide pair identified in the example. B, A specific CV term is added to the
header of the file to indicate that this is a cross-linking search result set. C, The two peptide chains identified from a given spectrum are
presented in a pair of Peptide and Modification elements linked via a shared, unique value in the cvParam element. The longer
peptide is flagged as the cross-link donor (carrying the mass of the cross-linking reagent) and the other peptide is flagged as the cross-link
acceptor with a zero mass on the Modification. D, The evidence for individual identifications is captured via two SpectrumIdentificatio-
nItem elements, which may share the same score (cvParam) for the paired identification, but may also store different, individual scores
for each chain identified if appropriate (not shown).
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used is the peptide sequence itself (because when grouping
by sequence irrespective of the modification status, this value
must be unique), although this could be any arbitrary value
such as an integer code. Finally, the mzIdentML file must be
able to record scores or statistical values at the peptide-level.
This is achieved via adding CV terms with identical values to
all PSMs within the same peptide-group. There are now
branches within the PSI-MS CV providing different scores for
PSMs and peptides from which suitable terms can be
sourced. The use of peptide-level scoring and export to
mzIdentML 1.2 has already been added to PeptideShaker (14)
and ProteoAnnotator (19).
Encoding Proteogenomics Approaches—Proteogenomics
data requires storing the results of mapping peptide se-
quences identified back onto gene models and source chro-
mosomes potentially coming from different genome builds.
This is achieved in mzIdentML 1.2 as follows. First, an addi-
tional CV term “proteogenomics search” (MS:1002635) is in-
cluded in SpectrumIdentificationProtocol (supplemental
Fig. S2). CV terms have been created to enable the mapping
of peptides back to specific positions on chromosomes, ac-
counting for regions where it has been inferred that a peptide
is mapped across an intron boundary to different exons. CV
terms related to peptide sequences (e.g. peptide coordi-
nates, number of exons, etc) must be included in Peptide-
Evidence elements, whereas CV terms related to the gene
model/resulting protein (genome build, chromosome name
and strand) must be included in DBSequence elements
(representing the database protein sequence), as indicated in
supplemental Fig. S2.
Other Changes in mzIdentML 1.2—Various changes have
also been made in mzIdentML 1.2 and in the accompanying
implementation guidelines to better accommodate four addi-
tional common use cases: pre-fractionation of samples, ap-
proaches for de novo sequencing of peptides, spectral library
searches and the use of multiple search engines in one com-
bined analysis. We have also significantly improved the re-
porting of protein-level results, derived by protein inference,
which was reported in detail here (35).
Prefractionation—A single mzIdentML file is intended to
encompass the analysis of a single sample, either as a result
of a single MS run, or as the end result of multiple MS runs
from the same sample where pre-fractionation has occurred.
However, to simplify the reading of mzIdentML files by soft-
ware, in both mzIdentML 1.1 and continued in mzIdentML 1.2,
there is a restriction that only a single list of proteins (one
ProteinDetectionList) can be given in one file, although
multiple SpectrumIdentificationList elements can be pro-
vided. We have amended the specification document to clar-
ify the cases where one or many mzIdentML files are ex-
pected in cases of sample pre-fractionation. In brief, where
protein inference is performed over n lists of PSMs (one per
fraction) to produce a single protein list, this should be stored
in a single mzIdentML file with n SpectrumIdentification-
List elements and a single ProteinDetectionList. If pro-
tein inference happens independently on each fraction, then n
mzIdentML files should be used, each containing a single
SpectrumIdentificationList and one ProteinDetection-
List. For a fuller discussion, consult the mzIdentML 1.2.
specification document available from the PSI website.
Multiple Search Engines—It has been widely reported that
there are gains in sensitivity for peptide and protein identifi-
cation through the use of multiple search engines (38–40). In
mzIdentML 1.1, it was already described how such ap-
proaches could be encoded and exported from software, but
the resulting scheme was difficult to implement for reading
software. The challenge arises because an mzIdentML 1.1 file
could contain the search engine results as reported by the
original search engines, as well as list of rescored PSMs,
which were used for protein inference, and constitute the
“final” results of the process. As such, in mzIdentML 1.2, we
have specified that there can only be a single result for each
spectrum searched (i.e. the spectrum identifier is unique
within the file), thus enforcing that only “final” results after
performing post-processing or combination can be validly
reported.
De Novo Sequencing—There are several software pack-
ages that aim to derive complete or near complete peptide
sequences directly from the spectrum without requiring a
sequence database. The mzIdentML 1.1 specifications dis-
cussed that such approaches could theoretically be sup-
ported, but relevant examples files were not produced at the
time because of an apparent lack of demand. It has since
become evident that supporting de novo results was not
straightforward, as there was a mandatory requirement for
every PSM reported to record one to many relationships to
protein sequences (see PeptideEvidenceRef on Fig. 1A
and PeptideEvidence on Fig. 1C). In de novo approaches
there is no need to relate a peptide sequence to a parent
protein, and as such this cardinality has been relaxed to zero
to many in mzIdentML 1.2, only when the export software
includes the CV term as a “flag” in the Spectrum-
IdentificationProtocol “de novo search” (MS:1001010). In
other cases, the validation software will then report an error if
relationships to one or more proteins are not recorded for any
PSMs.
Spectral Library Searching—mzIdentML 1.2 can also sup-
port searches against pre-annotated spectral libraries. The
standard case for representing PSMs is modeled with scores
or statistics on SpectrumIdentificationItem referencing to
a Peptide element. For sequence database searches,
Peptide stores the (sequence) database entry against
which a spectrum has been matched. For spectral library
searches, Peptide should store a representation of the
spectral library entry, annotated with any metadata about
the library entry (such as confidence scores or metrics for the
entry itself), with or without a peptide sequence depending on
what is contained within the library (i.e. matches against pre-
mzIdentML Data Standard Version 1.2
Molecular & Cellular Proteomics 16.7 1283
viously unidentified library entries can be supported). As for
de novo sequencing, it is not mandatory either to provide links
between peptides and database proteins (DBSequence
elements) from which the peptide sequence could have been
derived, because these associations may be unknown.
Guide on Implementing New Features in mzIdentML 1.2—In
this article we describe several extensions to mzIdentML, and
introduce version 1.2 from version 1.1, to support use cases
that were not anticipated previously. However, aside from
required minor changes to cardinality in several places (a few
attributes changing to become optional or mandatory), the
resulting XML schema for mzIdentML 1.2 is identical to
mzIdentML 1.1. As such, we anticipate that for groups who
have already implemented mzIdentML, only minor changes
would be required to accommodate both mzIdentML 1.1 and
1.2 files. We expect that mzIdentML 1.1 files will remain in
circulation for several years. The changes made to mzIdentML
1.2 can be described as backwards compatible, in that read-
ing software designed for mzIdentML 1.1 should function in
most cases without adaptation. However, for new implement-
ers of mzIdentML for export from software, we strongly en-
courage developers to follow the mzIdentML 1.2 guidelines.
In the case of cross-linking, this is still a relatively special-
ized field, and thus it would not be expected for general
reading software to be able to handle the extensions de-
scribed beyond general reading of PSMs now. Peptide-level
statistics and modification location scoring are becoming
more prevalent in proteome informatics, and thus we strongly
encourage development teams to support these features for
both file reading and writing.
CONCLUSIONS
The mzIdentML standard for peptide and protein identifica-
tion data has been stable for around five years, and has
steadily grown in use to support data interchange between
software tools, as well as a data repository submission for-
mat. Here we report updates to the standard to enhance its
support and usability for unanticipated requirements when the
standard was initially released. We have attempted to encode
these use cases without adapting the core model of the
format to simplify adoption by the developer community.
The PSI remains a free and open consortium of interested
parties, and we encourage critical feedback, suggestions and
contributions via attendance at a PSI annual meeting, confer-
ence calls or our mailing lists (see http://www.psidev.info/).
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